Noxopharm Limited (ASX:NOX)
Australia
· Delayed Price · Currency is AUD 0.0570
-0.0030 (-5.00%)
Mar 10, 2026, 1:01 PM AEST
Noxopharm Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | -5.49 | -4.88 | -3.58 | -15.06 | -18.67 | -9.35 | Upgrade
|
| Depreciation & Amortization | 0 | 0 | 0 | 0.15 | 0.26 | 0.26 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 0.06 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.47 | -0.47 | -1.05 | 4.45 | 8.86 | -8.77 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | - | - | 1.04 | Upgrade
|
| Stock-Based Compensation | 0.06 | 0.06 | - | 0.01 | 0.8 | 1.72 | Upgrade
|
| Other Operating Activities | -0.93 | -0.09 | 0 | 0.02 | 0.08 | 2.64 | Upgrade
|
| Change in Accounts Receivable | -0.57 | -0.57 | 3.7 | -0.48 | 0.18 | -1.14 | Upgrade
|
| Change in Inventory | - | - | - | 1.15 | -0.83 | 0.21 | Upgrade
|
| Change in Accounts Payable | 0.08 | 0.08 | 0.2 | -1.08 | -4.33 | 4.34 | Upgrade
|
| Change in Other Net Operating Assets | 0.04 | 0.04 | 0.03 | -0.18 | -0.08 | 0.19 | Upgrade
|
| Operating Cash Flow | -7.27 | -5.82 | -0.68 | -10.95 | -13.73 | -8.85 | Upgrade
|
| Investment in Securities | 2.48 | 2.48 | - | - | - | - | Upgrade
|
| Other Investing Activities | - | - | - | 0.12 | - | - | Upgrade
|
| Investing Cash Flow | 2.48 | 2.48 | - | 0.12 | - | 0.23 | Upgrade
|
| Short-Term Debt Issued | - | 4.4 | 2 | - | - | - | Upgrade
|
| Total Debt Issued | 3.85 | 4.4 | 2 | - | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -1.8 | -2 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -0.18 | -0.23 | -0.24 | Upgrade
|
| Total Debt Repaid | - | -1.8 | -2 | -0.18 | -0.23 | -0.24 | Upgrade
|
| Net Debt Issued (Repaid) | 3.85 | 2.6 | - | -0.18 | -0.23 | -0.24 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 1.2 | 30.1 | Upgrade
|
| Other Financing Activities | - | - | - | - | - | -1.53 | Upgrade
|
| Financing Cash Flow | 3.85 | 2.6 | - | -0.18 | 0.98 | 28.32 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0 | -0.02 | -0 | -0 | -0.03 | -0 | Upgrade
|
| Net Cash Flow | -0.95 | -0.77 | -0.69 | -11 | -12.79 | 19.7 | Upgrade
|
| Free Cash Flow | -7.27 | -5.82 | -0.68 | -10.95 | -13.73 | -8.85 | Upgrade
|
| Free Cash Flow Margin | -271.64% | -206.48% | -28.51% | -182.13% | -252.98% | -157.81% | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.02 | -0.00 | -0.04 | -0.05 | -0.03 | Upgrade
|
| Cash Interest Paid | 0.07 | 0.07 | 0.03 | 0.02 | 0.02 | 0.01 | Upgrade
|
| Cash Income Tax Paid | - | -2.34 | -6.05 | -5.01 | -5.86 | -4.64 | Upgrade
|
| Levered Free Cash Flow | -6.59 | -4.05 | 1.09 | -7 | -10.19 | -4.96 | Upgrade
|
| Unlevered Free Cash Flow | -6.01 | -3.73 | 1.11 | -6.97 | -10.15 | -3.59 | Upgrade
|
| Change in Working Capital | -0.45 | -0.45 | 3.94 | -0.59 | -5.07 | 3.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.